Close Menu

NEW YORK (GenomeWeb) – WaferGen Bio-systems announced that its shares have regained compliance for listing on the Nasdaq.

On Dec. 13, the Fremont, California-based firm received a letter from the market's Listing Qualifications Department acknowledging that the closing bid price of its common stock had been $1.00 or more for ten consecutive business days as of Dec. 12.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.